These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 8799494)

  • 1. Inhibition of P-glycoprotein-dependent multidrug resistance by an isoquinolinesulfonamide compound H-87 in rat ascites hepatoma AH66 cells.
    Nakamura S; Minamino T; Nomura M; Wakusawa S; Miyamoto K; Hidaka H
    Biol Pharm Bull; 1996 Jun; 19(6):886-9. PubMed ID: 8799494
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increase of vinblastine accumulation by inhibitors of calmodulin-dependent cell functions in rat ascites hepatoma AH66 cells.
    Wakusawa S; Takeda K; Miyamoto K; Hidaka H
    Anticancer Res; 1992; 12(6B):2021-4. PubMed ID: 1363514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multidrug resistance in Yoshida rat ascites hepatoma cell lines.
    Miyamoto K; Wakusawa S; Nakamura S; Tajima K; Hidaka H
    Anticancer Res; 1992; 12(3):649-53. PubMed ID: 1622121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of naturally acquired multiple-drug resistance of Yoshida rat ascites hepatoma AH66 cell line.
    Miyamoto K; Wakabayashi D; Minamino T; Nomura M; Wakusawa S; Nakamura S
    Anticancer Res; 1996; 16(3A):1235-40. PubMed ID: 8702243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sensitivity to antitumor drugs and vinblastine binding to membrane in rat ascites hepatoma AH66 cells.
    Wakusawa S; Nakamura S; Inoko K; Miyamoto K
    Chem Pharm Bull (Tokyo); 1992 Aug; 40(8):2182-4. PubMed ID: 1423778
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overcoming of vinblastine resistance by isoquinolinesulfonamide compounds in adriamycin-resistant leukemia cells.
    Wakusawa S; Nakamura S; Tajima K; Miyamoto K; Hagiwara M; Hidaka H
    Mol Pharmacol; 1992 Jun; 41(6):1034-8. PubMed ID: 1614407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Indoloquinoxaline compounds that selectively antagonize P-glycoprotein.
    Smith CD; Myers CB; Zilfou JT; Smith SN; Lawrence DS
    Oncol Res; 2000; 12(5):219-29. PubMed ID: 11417747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro and in vivo reversal of P-glycoprotein-mediated multidrug resistance by a novel potent modulator, XR9576.
    Mistry P; Stewart AJ; Dangerfield W; Okiji S; Liddle C; Bootle D; Plumb JA; Templeton D; Charlton P
    Cancer Res; 2001 Jan; 61(2):749-58. PubMed ID: 11212278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reversal activity of cyclosporin A and its metabolites M1, M17 and M21 in multidrug-resistant cells.
    Toffoli G; Corona G; Sorio R; Bertola A; Boiocchi M
    Int J Cancer; 1997 May; 71(5):900-6. PubMed ID: 9180163
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reversal of multidrug resistance by 7-O-benzoylpyripyropene A in multidrug-resistant tumor cells.
    Rho MC; Hayashi M; Fukami A; Obata R; Sunazuka T; Tomoda H; Komiyama K; Omura S
    J Antibiot (Tokyo); 2000 Oct; 53(10):1201-6. PubMed ID: 11132967
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular pharmacokinetic aspects of reversal effect of itraconazole on P-glycoprotein-mediated resistance of anticancer drugs.
    Takara K; Tanigawara Y; Komada F; Nishiguchi K; Sakaeda T; Okumura K
    Biol Pharm Bull; 1999 Dec; 22(12):1355-9. PubMed ID: 10746169
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BIBW22 BS, potent multidrug resistance-reversing agent, binds directly to P-glycoprotein and accumulates in drug-resistant cells.
    Liu Z; Lheureux F; Pouliot JF; Heckel A; Bamberger U; Georges E
    Mol Pharmacol; 1996 Sep; 50(3):482-92. PubMed ID: 8794885
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of anthracycline analogs on photolabelling of p-glycoprotein by [125I]iodomycin and [3H]azidopine: relation to lipophilicity and inhibition of daunorubicin transport in multidrug resistant cells.
    Friche E; Demant EJ; Sehested M; Nissen NI
    Br J Cancer; 1993 Feb; 67(2):226-31. PubMed ID: 8094288
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of P-glycoprotein in heat- and/or drug-resistant hepatoma variants.
    Pirity M; Hevér-Szabó A; Venetianer A
    Cytotechnology; 1996; 19(3):207-14. PubMed ID: 8862008
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reversal of vinblastine resistance in human leukemic cells by haloperidol and dihydrohaloperidol.
    Kataoka Y; Ishikawa M; Miura M; Takeshita M; Fujita R; Furusawa S; Takayanagi M; Takayanagi Y; Sasaki K
    Biol Pharm Bull; 2001 Jun; 24(6):612-7. PubMed ID: 11411546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of isoquinolinesulphonamide compounds on multidrug-resistant P388 cells.
    Nakamura S; Wakusawa S; Tajima K; Miyamoto K; Hagiwara M; Hidaka H
    J Pharm Pharmacol; 1993 Apr; 45(4):268-73. PubMed ID: 8098366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of vinblastine resistance by a new staurosporine derivative, NA-382, in P388/ADR cells.
    Miyamoto K; Wakusawa S; Inoko K; Takagi K; Koyama M
    Cancer Lett; 1992 Jun; 64(2):177-83. PubMed ID: 1351792
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Azidopine noncompetitively interacts with vinblastine and cyclosporin A binding to P-glycoprotein in multidrug resistant cells.
    Tamai I; Safa AR
    J Biol Chem; 1991 Sep; 266(25):16796-800. PubMed ID: 1679434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reversal of P-glycoprotein-mediated multidrug resistance by ginsenoside Rg(3).
    Kim SW; Kwon HY; Chi DW; Shim JH; Park JD; Lee YH; Pyo S; Rhee DK
    Biochem Pharmacol; 2003 Jan; 65(1):75-82. PubMed ID: 12473381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reversal of acquired resistance to doxorubicin in K562 human leukemia cells by astemizole.
    Ishikawa M; Fujita R; Takayanagi M; Takayanagi Y; Sasaki K
    Biol Pharm Bull; 2000 Jan; 23(1):112-5. PubMed ID: 10706423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.